Subjects: Data Analysis and Government Regulation - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Data Analysis ✖ Subjects Government Regulation ✖

1. COVID-19: HHS’s collection of hospital capacity data : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, August 2021
Subject(s):: COVID-19 -- economics
Data Analysis
Government Regulation
Surge Capacity -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

2. Medicare Advantage organizations are missing opportunities to use ordering provider identifiers to protect program integrity

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, April 2021
Subject(s):: Data Analysis
Fraud -- prevention & control
Government Regulation
Medical Order Entry Systems
Medicare Part C -- economics
United States
United States. Department of Health and Human Services

3. VA health care: Incomplete information hinders usefulness of market assessments for VA facility realignment : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, February 2022
Subject(s):: Capacity Building -- economics
Data Analysis
Government Regulation
Hospitals, Veterans
United States
United States. Department of Veterans Affairs

4. Medicare Part B drug payments: impact of price substitutions based on 2020 average sales prices

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Data Analysis
Drug Costs
Government Regulation
Medicare Part B
United States

5. A resource guide for using Medicare’s enrollment race and ethnicity data

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2023
Subject(s):: Data Analysis
Ethnicity
Government Regulation
Healthcare Disparities
Medicare
Racial Groups
Race Factors
United States

6. Some skin substitute manufacturers did not comply with new ASP reporting requirements

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2023
Subject(s):: Data Analysis
Government Regulation
Manufacturing Industry -- legislation & jurisprudence
Skin, Artificial
United States

7. Challenges with vaccination data hinder state and local immunization program efforts to combat COVID-19

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2023
Subject(s):: COVID-19 -- prevention & control
COVID-19 Vaccines
Data Accuracy
Data Analysis
Government Regulation
Immunization Programs
United States

8. Toolkit: analyzing telehealth claims to assess program integrity risks

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, April 2023
Subject(s):: Data Analysis
Fraud -- prevention & control
Government Regulation
Insurance Claim Review
Medicaid
Medicare
Telemedicine
United States

9. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.